|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 213/82 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 31/44 | (2006.01) |
| (11) | Patento numeris | 3436446 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17716763.2 |
| Europos patento paraiškos padavimo data | 2017-03-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/025381 |
| Data | 2017-03-31 |
| (87) | Numeris | WO 2017/173274 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 201662316043 P | 2016-03-31 | US |
| (72) |
BEAR, Brian , US
CLEMENS, Jeremy , US
CLEVELAND, Thomas , US
COON, Timothy, Richard , US
GROOTENHUIS, Peter, Diederik Jan , US
FRIEMAN, Bryan, A. , US
HADIDA RUAH, Sara S. , US
KHATUYA, Haripada , US
KRENITSKY, Paul, J. , US
MILLER, Mark, Thomas , US
SILINA, Alina , US
UY, Johnny , US
ZHOU, Jinglan , US
|
| (73) |
Vertex Pharmaceuticals Incorporated ,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |